Over 1.4 million male circumcisions are performed annually in U.S. medical settings. However, population-based estimates of male circumcision associated adverse events are lacking.
To estimate the incidence rate of male circumcision associated adverse events, and assess whether adverse event rates differed by age at circumcision.
We selected 41 possible male circumcision adverse events based on literature review and medical billing codes. We estimated a likely risk window for incidence calculation for each male circumcision adverse event based on pathogenesis. We used 2001 – 2010 data from SDIhealth, a large administrative claims dataset, to conduct a retrospective cohort study.
SDIhealth provided administrative claims data from inpatient and outpatient U.S. medical settings.
For each adverse event, we calculated incidence per million male circumcisions. We compared incidence risk ratio and incidence rate difference for: a) circumcised vs. uncircumcised newborn males, and b) males circumcised at ≤1 year, 1–9 years, or ≥10 years of age. An adverse event was considered probably related to male circumcision if the incidence risk ratio significantly exceeded one at p<0.05 or occurred only in circumcised males.
Records were available for 1,400,920 circumcised males, 93.3% as newborns. Of the 41 possible male circumcision adverse events, 16 (39%) were probable. Incidence of total male circumcision adverse event was slightly less than half percent. Rates of potentially serious male circumcision adverse events ranged from 0.76 per million male circumcision (95% CI: 0.10 – 5.43) for stricture of male genital organs to 703.23 per million male circumcision (95% CI: 659.22 – 750.18) for repair of incomplete circumcision. Compared to males circumcised at ≤1 year of age, the incidence was approximately 20- and 10-fold greater for males circumcised between 1 – 9 years and those ≥10 years of age, respectively.
male circumcision had a relatively low incidence of adverse events overall, especially if the procedure was performed during the first year of life, but rose 10–20 fold when performed after infancy.
The American Academy of Pediatrics (AAP) updated its guidance on male circumcision (MC) in 2012 to state “the procedure’s benefits justify access to this procedure for families who choose it.”
Several studies have reported on MC AE, from mild to severe, ranging from 0.0008% to 3.6% in infants and from 0.9% to 8.8% in adults.
SDIhealth (Plymouth Meeting, PA) consolidates U.S. electronic healthcare reimbursement claims. SDIhealth data include International Classification of Diseases, 9th revision (ICD-9) and Current Procedural Terminology (CPT) codes, and are available about two months after clinical visits. SDIhealth creates a unique anonymous identifier for each patient, enabling individuals to be followed longitudinally.
The Charge Data Master (CDM) is SDIhealth’s inpatient dataset. It gathers data from a 20% convenience sample of all inpatient encounters of short-stay, acute care, and non-federal hospitals from 48 states and Washington DC, representing ~120 million unique hospitalized patients. CDM hospitals are located in all U.S. regions (25% East, 12% North, 45% South, 16% West, and data on regions is unspecified for 2%). Of these hospitals, 85% are urban, 36% are teaching, with a wide variability of bed-size (median size 200–299 beds). Of patients seen at these hospitals, about 10% of patients are covered by Medicaid, 30% by Medicare, and the remainder covered by Third Party payers. CDM data is formed by two datasets: CDM1 (~80% of CDM) is available since 2001 and updated monthly; only the month of diagnosis or procedure is provided, with date of discharge defaulted to the first day of the discharge month. CDM2 (~20% of CDM), is available since 2005 and updated weekly; unlike CDM1, the exact discharge date of a diagnosis or a procedure is available. SDIhealth also collects data from >870,000 unique outpatient medical providers with the exact discharge date of diagnoses and procedures. For this study, we used CDM data available through February 2010.
For each of the 41 possible MC AE, one of the co-authors who is a board-certified pediatric urologist (CSC),
We edited the CDM MC dataset by a) removing circumcised males who had a MC date prior to their birth date, and b) reclassified newborn males who did not have a MC record but had a MC-specific AE (CPT: 54162 and 54163) as circumcised.
We performed a retrospective cohort study using log binomial regression modeling (SAS 9.2) to ascertain the risk associated with MC. We first calculated the incidence of each AE over its risk window, per million circumcised (and separately for uncircumcised) newborn males using discharge date of circumcision (or birth for uncircumcised) for the beginning of the risk window. We then calculated the IRR, IRD, and their respective 95% confidence interval (CI) between the circumcised and uncircumcised groups.
To minimize potential confusion on causal relationships in this exploratory study, the AE and person time outside the risk window in circumcised persons were deleted from analysis (instead of included in medical procedure-unexposed group as done in another risk window safety study).
We assessed if rates of probable MC AE differed in the following three age groups: males circumcised before one year of age (reference group), between one and nine years of age, and at age ten years or older. The age groups’ cut-off points separated infants from children prior to puberty and older males. We used the same statistical approach as above to calculate incidence per million male circumcisions (PMMC), IRR, IRD, and 95% CI.
To better detect rare MC AE, we first conducted the analysis using all available data including CDM1, CDM2, and outpatient datasets. Due to CDM1 day of discharge being defaulted to the first day of the month, all AE risk windows <28 days were reset to 28 days, the shortest risk window that could possibly be tracked, and the closest to a complete month, in this analysis (
During 2001–2010, 1,400,920 MC reimbursement claims for males of all ages were submitted from U.S. hospital settings and available to SDIhealth (CDM1, CDM2, outpatient data). Forty seven males (0.0033%) had a MC dated prior to their birth date and these records were removed from analysis. Also, of all newborn males, 346 (0.015%) had a MC-specific AE but did not have a MC record. These were reclassified as circumcised newborn males.
Data was available for a total of 2,339,760 newborn male births. Among these, 1,306,812 (55.8%) were linked to a circumcision record. Of the initial 41 possible MC AE, 16 (39%) met the criteria for probable MC AE (underlined in
There were 4,924 newborns, 4,059 circumcised and 865 uncircumcised, with one or more probable AE. In total, there were 5,385 and 1,100 AE recorded among circumcised and uncircumcised newborns, respectively. Of the 4,924 total, 4,523 (91.8%) were cared for in a hospital setting and 401 in outpatient setting. The estimated incidence of probable AE associated with MC was less than one percent, either crude [4.059/1,306,812 = 0.31% (95% CI = 0.30 – 0.32)] or adjusting for the background rate [(4,059/1,306,812) - (865/1,032,948) = 0.23% (95%CI = 0.21 – 0.24)].
The IRD for potential serious probable AE ranged from a low of 0.76 persons with Stricture of male genital organ PMMC (95%CI: 0.10 – 5.43) to a high of 703.23 persons with repair of incomplete circumcision PMMC (95%CI: 659.22 – 750.18). The most common probable MC AE was Division of penile adhesions [199.69 PMMC (95%CI: 153.92 – 245.66)].
Nine AE were significantly less likely to occur in circumcised compared to uncircumcised infants at p<0.05.
Circumcised newborn males had a higher risk for Wounds, Correctional procedures, Inflammations, and Bleedings compared to uncircumcised ones, but a lower risk for Surgical procedures, Penile disorders and gangrene, Pneumothorax and Infections.
Among the extremely rare but serious AE occurring only among circumcised newborns (but once or none among uncircumcised), we found no cases of Complete amputation of penis, three cases of Partial amputation of penis four cases of Replantation of penis,16 cases of Suture of artery, and one case of Stricture of male genital organs.
Of the 1,400,920 circumcised males, 1,335,180 (95.3%) male infants were circumcised during infancy. Another 28,197 (2.0%) males were circumcised between age one and nine years, and 37,543 (2.7%) males were circumcised at age ≥10 years [8590 (22.9%) of whom were 10 – 18 years old]. Incidence of probable AE varied by age group: 0.40% (95% CI 0.39 – 0.41) among males circumcised during infancy; 9.06% (95% CI 8.73 – 9.40) among males circumcised between age one and nine years, and 5.31% (95% CI 5.09 – 5.55) among males circumcised at age ≥ten years; or approximately 20- and 10-fold higher for the older age groups compared to infants, respectively.
Except for the comparisons in which no AE cases occurred in one or both of the older age groups, the IRR of each of the other studied AE comparisons significantly exceeded one and IRD exceeded 100 PMMC (except for Suture of artery) when MC was performed after the first year of life. The highest IRR among males circumcised between one and nine years of age was found for Division of penile adhesions (IRR = 67.64; 95% CI: = 61.98 – 73.81). The highest IRR among males circumcised at age ≥ 10 years was found for Other inflammatory disorders of penis (IRR = 112.06; 95% CI: = 93.88 – 133.75). While these are not explicitly defied in the ICD-9 manual, they can be skin condition such as infection, cellulitis, abscess, boil, carbuncle, or cavernitis.
We studied the AE outcomes after ~1.4 million MC in the United States, about 10 fold larger than the largest prior studies.
Our findings also suggest that many AE such as penile reconstruction, pneumothorax and infections occur less frequently in circumcised males, perhaps due to a “healthy baby” bias – those newborns who undergo MC are more likely to be healthier (and without such disorders) compared to their uncircumcised counterparts. This type of selection bias is commonly seen in non-randomized observational studies of outcomes after medical procedures
We found the incidence of MC AE was 10 – 20-fold higher when performed at older age groups compared to infancy. These findings are consistent with earlier studies
The incidence of amputations was highest among males circumcised at ten years of age or older: 0.17% (95% CI: 0.13 – 0.21%). In total, the absolute number of amputations in our database was 71. Most penile amputations captured in our dataset (45 out of 71) are recorded using ICD-9 code 643.0 which does not differentiate complete from partial penile amputation. Of the 71 recorded amputations, three were coded as complete — one among males circumcised in infancy, and two among males circumcised at ten years of age or older. Wiswell reported the absence of total penile amputations over five years in a study of MC AE among newborns from U.S. Army hospital settings
Our study has several potential limitations. First, most of our data (~80%) assigns a discharge date of the first day of the month for the medical record. Hence, in the case where the AE has a risk window of < 28 days and falls in the same month of the MC it will be counted even if it occurs outside of the risk window. Also, in the case where an AE has a risk window of < 28 days and is encountered during the month following MC, it will be missed. The first scenario tends to over count some AE while the second tends to undercount some others. However, limiting our analysis to data with exact discharge date, our findings remained almost unchanged (eResults,
A third limitation is that our data may not be generalized to the entire U.S. population as it came from a convenience sample. However,, the very large volume of administrative SDIhealth data used in this study (~20% of U.S. hospital discharges and >870,000 unique outpatient medical providers) strengthens our findings. A recent publication showed the trends in neonatal MC in SDIhealth data were virtually identical to that of two nationally representative datasets
A fourth limitation of our data was that it was collected for billing purposes only. If a circumcision or an AE was not covered by a third party payer, it would be missing from this analysis. Also, some circumcisions might occur in non-medical settings, such as religious MC, but a resulting AE might require medical intervention, and hence be captured as occurring among uncircumcised newborns. Indeed, some uncircumcised newborn males in our data had a MC-specific AE. However, these did not exceed 0.01% of all newborns and the incidence of AE in our analysis was in the range of those from previous U. S. publications.
Finally, MC can occur concurrently with other operative procedures for anesthesia-convenience reasons. The AE that might result from these cases might be confounded by other health conditions of the patient. Future studies overcoming these limitations and examining other databases to confirm our findings are needed to better estimate specific AE rates attributable only to MC.
Our data suggest the rate of AE associated with newborn circumcision is less than half percent. Importantly, the incidence of AE increased substantially when MC occurred after the first year of life. Given the current debate about whether MC should be delayed from infancy to adulthood for autonomy reasons
The authors wish to thank:
Farid Khan MPH, Laurel Edelman BS, and Joel Greenspan, MD, of SDI Health, for answering our inquiries about the data Kris Greiner BA from the Division of Pediatric Urology, The University of Iowa, for formatting the manuscript to adhere with JAMA Pediatrics’ style Sanjyot Shinde, PhD, Deborah Gust, PhD, and Charles LeBaron, MD, Division of HIV/AIDS Prevention, CDC, for their valuable assistance in reviewing and providing valuable comments for this manuscript.
The corresponding author, Dr. Charbel El Bcheraoui, confirms that written permission has been obtained from all persons named in the Acknowledgment section.
The authors have no financial relationships relevant to this article to disclose.
The authors have no conflicts of interest to disclose.
Charbel El Bcheraoui and Xinjian Zhang had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Charbel El Bcheraoui: Dr. El Bcheraoui assisted in conceptualizing this study, developed the analysis plan for this study, conducted the data analysis, drafted the original manuscript and approved the final manuscript as submitted.
Xinjian Zhang: Dr. Zhang assisted in developing the analysis methods, provided statistical analysis, and approved the final manuscript as submitted.
Christopher S. Cooper: Dr. Cooper assisted in conceptualizing this study, estimated risk windows to be used for adverse events analysis, acquisition, analysis, or interpretation of data, and approved the final manuscript as submitted.
Charles E. Rose: Dr. Rose assisted in developing the analysis methods, provided statistical analysis, and approved the final manuscript as submitted.
Peter H. Kilmarx: Dr. Kilmarx assisted in conceptualizing this study, provided guidance in data analysis and approved the final manuscript as submitted.
Robert T. Chen: Dr. Chen assisted in conceptualizing this study, provided guidance in data analysis, manuscript development, and approved the final manuscript as submitted.
Counts, incidence rates, incidence risk ratio, and incidence rate difference of adverse events between circumcised and uncircumcised newborn males. Charge Data Master 1 (CDM1), CDM2, and outpatient data, Unites States 2001 – 2010
| Adverse events | Count among uncircumcised | Count among circumcised | P value | Incidence Risk | Incidence Rate |
|---|---|---|---|---|---|
| 4 (3.87; 1.45 – 10.31) | 3 (2.29; 0.74 – 7.11) | 0.5 | 0.59 (0.13 – 2.64) | −1.58(−6.18 – 3.02) | |
| | 4 (3.87; 1.45 – 10.31) | 0 (0) | N.A. | N.A. | N.A. |
| | 0 (0) | 3 (2.29; 0.74 – 7.11) | N.A. | N.A. | 3 (2.29; 0.74 – 7.11) |
| 32 (30.97; 21.90 – 43.80) | 89 (68.10; 55.32 – 83.83) | <0.001 | 2.19 (1.46 – 3.29) | 37.12(19.37 – 54.88) | |
| | 29 (28.07; 19.51 – 40.40) | 83 (63.51; 51.21 – 78.75) | <0.001 | 2.26 (1.48 – 3.45) | 35.44(18.38 – 52.50) |
| | 3 (2.90; 0.93 – 9.00) | 6 (4.59; 2.06 – 10.21) | 0.5 | 1.58 (0.39 – 6.32) | 1.68(−3.24 – 6.62) |
| 644 (623.45; 577.13 – 673.50) | 3281 (2510.69; 2426.33 – 2597.97) | <0.001 | 4.02 (3.70 – 4.38) | 1887.23(1778.85 – 1985.62) | |
| | 43 (41.62; 30.87 – 56.12) | 293 (224.21; 199.95 – 251.40) | <0.001 | 5.38 (3.91 – 7.41) | 182.58(154.06 – 211.11) |
| | 55 (53.24; 40.88 – 69.35) | 299 (228.80; 204.28 – 256.25) | <0.001 | 4.29 (3.22 – 5.72) | 175.56(146.05 – 205.06) |
| | 64 (61.95; 48.49 – 79.15) | 15 (11.47; 6.91 – 19.03) | <0.001 | 0.18 (0.10 – 0.32) | −50.48(−66.03 – −34.23) |
| | 77 (74.54; 59.62 – 93.19) | 30 (22.95; 16.05 – 32.83) | <0.001 | 0.30 (0.20 – 0.46) | −51.59(−70.15 – −23.02) |
| | 0 (0) | 4 (3.06; 1.14 – 8.15) | N.A. | ||
| | 1 (0.96; −0.13 – 6.87) | 4 (3.06; 1.14 – 8.15) | 0.3 | 3.16 (0.35 – 28.28) | 2.09(−1.46 – 5.64) |
| | 181 (175.22; 151.47 – 202.70) | 354 (270.88; 244.09 – 300.62) | <0.001 | 1.54 (1.29 – 1.84) | 95.66(57.61 – 133.71) |
| | 277 (268.16; 238.37 – 301.67) | 715 (547.13; 508.47 – 588.73) | <0.001 | 2.04 (1.77 – 2.34) | 278.97(227.93 – 330.00) |
| | 234 (226.53; 199.29 – 257.49) | 557 (426.22; 392.26 – 463.12) | <0.001 | 1.88 (1.61 – 2.19) | 199.69(153.92 – 245.66) |
| | 0 (0) | 757 (579.27; 539.45 – 622.02) | N.A. | N.A. | 757 (579.27; 539.45 – 622.02) |
| | 0 (0) | 919 (703.23; 659.22 – 750.18) | N.A. | N.A. | 919 (703.23; 659.22 – 750.18) |
| 224 (216.85; 190.24 – 247.19) | 52 (39.79; 30.32 – 52.21) | <0.001 | 0.18 (0.13 – 0.240 | −177.06(−207.65 – −146.68) | |
| Incision of penis | 186 (180.06; 155.96 – 207.89) | 21 (16.07; 10.47 – 24.64) | <0.001 | 0.08 (0.05 – 0.14) | −163.99(−190.77 – −137.22) |
| Incision of penis | 202 (195.55; 170.36 – 224.46) | 35 (26.78; 19.22 – 37.30) | <0.001 | 0.13 (0.09 – 0.19) | −168.77(−197.16 – −140.39) |
| | 22 (21.29; 14.02 – 32.34) | 17 (13.00; 8.08 – 20.92) | 0.1 | 0.61 (0.32 – 1.15) | −8.29(−19.13 – 2.54) |
| 1062 (1028.12; 968.14 – 1091.82) | 799 (611.41; 570.46 – 655.29) | <0.001 | 0.59 (0.54 – 0.65) | −416.71(−491.65 – −341.77) | |
| | 11 (10.64; 5.89 – 19.22) | 70 (53.56; 42.37 – 67.70) | <0.001 | 5.03 (2.66 – 9.49) | 42.92(28.88 – 56.95) |
| Other specified disorders of penis | 934 (904.20; 849.06 – 964.06) | 638 (488.21; 451.76 – 527.59) | <0.001 | 0.59 (0.53 – 0.65) | −415.99(−485.24 – −346.76) |
| Unspecified disorders of penis | 87 (84.224; 68.26 – 103.91) | 78 (59.68; 47.80 – 74.51) | 0.02 | 0.70 (0.52 – 0.96) | −24.54(−46.64 – 2.43) |
| | 30 (29.04; 20.30 – 41.53) | 13 (9.94; 5.77 – 17.13) | 0.001 | 0.34 (0.17 – 0.65) | −19.09(−30.81 – −7.38) |
| 263 (254.61; 225.62 – 287.31) | 120 (91.82; 76.78 – 109.81) | <0.001 | 0.36 (0.29 – 0.44) | −162.78(−197.66 – −127.91) | |
| | 144 (139.40; 118.40 – 164.13) | 66 (50.50; 39.67 – 64.28) | <0.001 | 0.36 (0.27 – 0.48) | −88.90(−114.73 – −63.08) |
| | 119 (115.20; 96.25 – 137.87) | 54 (41.32; 31.64 – 53.95) | <0.001 | 0.35 (0.26 – 0.49) | −73.88(−97.33 – 50.43) |
| 842 (815.14; 761.92 – 872.07) | 834 (638.19; 596.33 – 682.99) | <0.001 | 0.78 (0.71 – 0.86) | −176.95(−246.98 – −106.92) | |
| | 2 (1.93; 0.48 – 7.74) | 2 (1.53; 0.38 – 6.11) | 0.99 | 0.79 (0.11 – 5.61) | −0.41(−3.82 – 3.01) |
| | 415 (401.76; 364.91 – 442.32) | 399 (305.32; 276.79 – 336.79) | <0.001 | 0.76 (0.66 – 0.87) | −96.44(−145.34 – −47.54) |
| | 9 (8.71; 4.53 – 16.74) | 5 (3.82; 1.59 – 9.19) | 0.1 | 0.43 (0.14 – 1.31) | −4.98(−11.49 – 1.72) |
| | 160 (154.89; 132.66 – 180.85) | 207 (158.40; 138.22 – 181.51) | 0.8 | 1.02 (0.83 – 1.25) | 3.50(−28.77 – 35.78) |
| | 252 (243.96; 215.62 – 276.01) | 203 (155.34; 135.37 – 178.24) | <0.001 | 0.63 (0.52 – 0.76) | −88.62(−125.55 – −51.69) |
| | 4 (3.87; 1.45 – 10.31) | 18 (13.77; 8.67 – 21.86) | 0.02 | 3.55 (1.20 – 10.50) | 9.90(2.49 – 17.31) |
| 313 (303.01; 271.24 – 338.50) | 616 (471.37; 435.59 – 510.10) | <0.001 | 1.55 (1.35 – 1.78) | 168.36(118.24 – 218.47) | |
| | 42 (40.66; 30.04 – 55.01) | 142 (108.66; 99.21 – 136.35) | <0.001 | 2.67 (1.89 – 3.77) | 68.00(46.31 – 89.69) |
| | 108 (104.55; 86.58 – 126.25) | 289 (221.14; 197.06 – 248.17) | <0.001 | 2.11 (1.69 – 2.63) | 116.59(84.36 – 148.82) |
| Other inflammatory disorders of male genitals | 17 (16.45; 10.23 – 26.47) | 35 (26.78; 19.22 – 37.30) | 0.09 | 1.62 (0.91 – 2.90) | 10.33(−1.0 – 22.15) |
| Edema of male genital organs | 146 (141.34; 120.18 – 166.23) | 150 (114.78; 97.80 – 134.70) | 0.07 | 0.81 (0.64 – 1.01) | −26.56(−55.94 – 2.82) |
| 73 (70.67; 56.18 – 88.89) | 104 (79.58; 65.66 – 96.44) | 0.4 | 1.12 (0.83 – 1.51) | 8.91(−13.37 – 31.19) | |
| | 1 (0.96; −0.13 – 6.87) | 8 (6.12; 3.06 – 12.24) | 0.08 | 6.32 (0.79 – 50.55) | 5.15(0.51 – 9.80) |
| | 72 (69.70; 55.32 – 87.81) | 95 (72.69; 59.45 – 88.88) | 0.78 | 1.04 (0.76 – 1.41) | 2.99(−18.75 – 24.74) |
| | 0 (0) | 1 (0.76; 0.10 – 5.43) | N.A. | 0.76 (0.10 – 5.43) | |
| 462 (447.26; 408.29 – 489.95) | 1889 (1445.50; 1381.80 – 1512.13) | <0.001 | 3.23 (2.91 – 3.57) | 998.24(921.39 – 1075.09) | |
| Unspecified hemorrhage of newborn | 44 (42.59; 31.69 – 57.23) | 37 (28.31; 20.51 – 39.07) | 0.06 | 0.66 (0.42 – 1.02) | −14.28(−29.82 – 1.26) |
| | 350 (338.83; 305.13 – 376.25) | 1614 (1235.06; 1176.29 – 1296.77) | <0.001 | 3.73 (3.31 – 4.19) | 896.23(826.33 – 966.13) |
| | 26 (25.17; 17.13 – 36.96) | 173 (132.38; 114.05 – 153.65) | <0.001 | 5.25 (3.48 – 7.94) | 107.21(85.24 – 129.18) |
| 0 (0) | 16 (12.24; 7.50 – 19.98) | N.A. | 12.24 (7.50 – 19.98) | ||
| | 32 (30.97; 21.90 – 43.80) | 30 (22.95; 16.05 – 32.83) | 0.2 | 0.74 (0.45 – 1.21) | −8.02(−21.59 – 5.94) |
| | 10 (9.68; 5.20 – 17.99) | 19 (14.53; 9.27 – 22.79) | 0.29 | 1.50 (0.69 – 3.22) | 4.86(−4.01 – 13.73) |
The total count for a group of adverse events was obtained by adding counts of all individual;
Risk window defined for 28 days post-circumcision or post-birth for circumcised males and uncircumcised males respectively
Risk window defined for 180 days post-circumcision or post-birth for circumcised males and uncircumcised males respectively
Risk window defined for 365 days post-circumcision or post-birth for circumcised males and uncircumcised males respectively
Risk window defined for 1200 days post-circumcision or post-birth for circumcised males and uncircumcised males respectively
Note: Adverse events that were not encountered in this analysis, i.e. had a count of zero, were not presented to reduce the length of the table. These are: complete amputation of penis, repair and plastic operation on penis, incision and drainage of penis.
CI: confidence interval
N.A.: not applicable
Counts, incidence rates and incidence risk ratio of adverse events between males circumcised at 3 different age groups. Charge Data Master 1 (CDM1), CDM2, and outpatient data, Unites States 2001 – 2010
| Adverse events | Age at circumcision | Count among circumcised males | Incidence Risk Ratios (95% | Incidence Rate Difference |
|---|---|---|---|---|
| < 1 year old | 8(5.99;3.00–11.99) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 63(1678.07; 1311.17 – 2147.64) | 81.29(33.44 – 197.58) | 420.94(212.12 – 629.75) | |
| < 1 year old | 0 (0) | Reference group | Reference group | |
| 1 – 9 years old | 0 (0) | N.A. | N.A. | |
| ≥ 10 years old | 45 (1198.62; 895.09 – 1605.08) | N.A. | 45 (1198.62; 895.09 – 1605.08) | |
| | < 1 year old | 7(5.24;2.50 – 11.00) | Reference group | Reference group |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 16(426.18; 261.12 – 695.58) | 81.29(33.44 – 197.58) | 420.94(212.12 – 629.75) | |
| < 1 year old | 1 (0.75; 2.50 – 11.01) | Reference group | Reference group | |
| 1 – 9 years old | 0 (0) | N.A. | N.A. | |
| ≥ 10 years old | 2 (53.27; 26.11 – 69.55) | 71.03 (6.44 – 783.35) | 52.52(−21.32–126.37) | |
| < 1 year old | 87 (65.25; 52.88 – 80.50) | Reference group | Reference group | |
| 1 – 9 years old | 11 (390.11; 216.06 – 704.34) | 5.97 (3.19 – 11.19)) | 324.95(94.05 – 555.86) | |
| ≥ 10 years old | 113 (3009.88; 2503.77 – 3618.28) | 46.12 (34.88 – 60.99)) | 2944.7(2390.4 – 3499.0) | |
| Open wound of penis w/out mention of complications | < 1 year old | 87 (65.25; 52.88 – 80.50) | Reference group | Reference group |
| 1 – 9 years old | 11 (390.11; 216.06 – 704.34) | 5.97 (3.19 – 11.19) | 324.95(94.05 – 555.86) | |
| ≥ 10 years old | 113 (3009.88; 2503.77 – 3618.28) | 46.12 (34.88 – 60.99) | 2944.7(2390.4 – 3499.0) | |
| < 1 year old | 4018(3009.3;2917.8 – 3103.7) | Reference group | Reference group | |
| 1 – 9 years old | 2947 (104515;101004 – 108147) | 34.73(33.17 – 36.37) | 101505(97933 – 105077) | |
| ≥ 10 years old | 1219 (32469;30725 – 34313) | 10.79(10.13 – 11.49) | 29460(27665 – 31255) | |
| < 1 year old | 314 (235.49; 210.84 – 263.03) | Reference group | Reference group | |
| 1 – 9 years old | 25 (886.61; 599.20 – 1311.90) | 3.76 (2.50 – 5.65) | 651.44(303.07 – 999.82) | |
| ≥ 10 years old | 55 (1464.98; 1124.97 – 1907.76) | 6.22 (4.67 – 8.28) | 1229.8(842.05 – 1617.6) | |
| < 1 year old | 322 (241.49; 216.51 – 269.36) | Reference group | Reference group | |
| 1 – 9 years old | 27 (957.74; 656.78 – 1396.03) | 3.96 (2.67 – 5.870 | 716.38(354.41 – 1078.4) | |
| ≥ 10 years old | 61 (1624.80; 1264.45 – 2087.84) | 6.72 (5.11 – 8.84) | 1383.6(975.37 – 1791.9) | |
| | < 1 year old | 4(3.00;1.12 – 7.98) | Reference group | Reference group |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 0 | N.A. | N.A. | |
| < 1 year old | 4(3.00;1.12 – 7.98) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 0 | N.A. | N.A. | |
| < 1 year old | 841 (630.74; 589.53 – 674.83) | Reference group | Reference group | |
| 1 – 9 years old | 468 (16598.00; 15171.34 – 18157.74) | 26.31 (23.51 – 29.44) | 15968(14476 – 17459) | |
| ≥ 10 years old | 394 (10495.00; 9512.83 – 11577.76) | 16.63 (14.76 – 18.74) | 9864.8(8833.1 – 10896) | |
| < 1 year old | 1213 (909.74; 859.98 – 962.38) | Reference group | Reference group | |
| 1 – 9 years old | 471 (16704.00; 15273.04 – 18268.81) | 18.36 (16.51 – 20.40) | 15795(14299 – 17292) | |
| ≥ 10 years old | 399 (16628; 9639.56 – 11717.37) | 11.68 (10.43 – 13.07) | 9719.3(8680.8 – 10758) | |
| < 1 year old | 841 (630.74; 589.53 – 674.83) | Reference group | Reference group | |
| 1 – 9 years old | 1203 (42664.00; 40369.23 – 45089.44) | 67.64 (61.98 – 73.81) | 42034(39675 – 44394) | |
| ≥ 10 years old | 489 (13025.00; 11927.20 – 14223.97) | 20.65 (18.48 – 23.07) | 12395(11247 – 13543) | |
| Lysis or excision of penile post-circumcision adhesions | < 1 year old | 685 (513.74; 476.68 – 553.68) | Reference group | Reference group |
| 1 – 9 years old | 369 (13086.00; 11825.03 – 14482.52) | 25.47 (22.45 – 28.89) | 12573(11246 – 13901) | |
| ≥ 10 years old | 116 (3089.79; 2576.43 – 3705.43) | 6.01 (4.94 – 7.32) | 2576.8(2014.0 – 3139.5) | |
| < 1 year old | 953 (714.74; 670.79 – 761.57) | Reference group | Reference group | |
| 1 – 9 years old | 877 (31103.00; 29140.98 – 33196.26) | 43.51 (39.73 – 47.65) | 30389(28362 – 32416) | |
| ≥ 10 years old | 154 (4101.96; 3503.81 – 4802.22) | 5.73 (4.84 – 6.80) | 3388.2(2740.1 – 4036.3) | |
| < 1 year old | 17 (12.73; 7.92 –20.48) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 9 (239.73; 124.74 – 460.70) | 18.83 (8.39 – 42.24) | 226.99 (70.27 – 383.71) | |
| Vascular disorders of Penis | < 1 year old | 17 (12.73; 7.92 –20.48) | Reference group | Reference group |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 9 (239.73; 124.74 – 460.70) | 18.83 (8.39 – 42.24) | 226.99 (70.27 – 383.71) | |
| < 1 year old | 18 (13.48; 8.49 –21.40) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 0 | N.A. | N.A. | |
| < 1 year old | 18 (13.48; 8.49 –21.40) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 0 | N.A. | N.A. | |
| < 1 year old | 470 (352.01;321.59 – 385.31) | Reference group | Reference group | |
| 1 – 9 years old | 191 (6773.77;5880.97 – 7802.11) | 16.45 (13.93 – 19.43) | 6421.8(5463.8 – 7379.7) | |
| ≥ 10 years old | 673 (17926.11;16632.98 – 19319.78) | 83.05 (74.11 – 93.07) | 17574(16232 – 18917) | |
| Other inflammatory disorders of penis / cellulites penis | < 1 year old | 161 (120.74; 103.46 – 140.91) | Reference group | Reference group |
| 1 – 9 years old | 111 (3936.58; 3269.54 – 4739.72) | 32.60 (25.60 – 41.50) | 3816.0(3084.9 – 4547.1) | |
| ≥ 10 years old | 508 (13531.00; 12411.52 – 14751.77) | 112.06 (93.88 – 133.75) | 13411(12242 – 14579) | |
| Edema of penis | < 1 year old | 309 (231.74; 207.29 – 259.07) | Reference group | Reference group |
| 1 – 9 years old | 80 (2837.18; 2279.58 – 3531.17) | 12.24 (9.57 – 15.65) | 2605.8(1984.4 – 3227.1) | |
| ≥ 10 years old | 165 (4394.96; 3774.28 – 5117.70) | 18.96 (15.70 – 22.90) | 4163.5(3493.9 – 4833.2) | |
| < 1 year old | 1(0.75;0.11 – 5.32) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 1(26.64;3.75 – 189.09) | 35.56(2.22 – 568.60) | 25.89(−26.34 – 78.11) | |
| < 1 year old | 1(0.75;0.11 – 5.32) | Reference group | Reference group | |
| 1 – 9 years old | 0 | N.A. | N.A. | |
| ≥ 10 years old | 1(26.64;3.75 – 189.09) | 35.56(2.22–568.60) | 25.89(−26.34 – 78.11) | |
| < 1 year old | 1998(1496.4;1432.3 – 1563.5) | Reference group | Reference group | |
| 1 – 9 years old | 279(9894.7;8804.3 – 11120) | 6.61(5.84 – 7.49) | 8398.2(7241.1 – 9555.4) | |
| ≥ 10 years old | 332(8843.2; 7945.1 – 9842.8) | 5.91(5.26 – 6.63) | 7346.8(6397.5 – 8296.1) | |
| Intra-operative bleeding | < 1 year old | 1779 (1334.23; 1273.69 – 1397.65) | Reference group | Reference group |
| 1 – 9 years old | 249 (8830.72; 7803.55 – 9993.10) | 6.61 (5.80 – 7.55) | 7498.3(6404.6 – 8592.1) | |
| ≥ 10 years old | 304 (8097.38; 7239.73 – 9056.62) | 6.06 (5.37 – 6.85) | 6765.0(5856.3 – 7673.7) | |
| < 1 year old | 200 (149.99; 130.58 – 172.29) | Reference group | Reference group | |
| 1 – 9 years old | 27 (957.54; 656.78 – 1396.03) | 6.38 (4.27 – 9.53) | 807.76(446.14 – 1169.4) | |
| ≥ 10 years old | 27 (719.17; 714.17 – 1360.00) | 4.79 (3.20 – 7.16) | 569.38(297.41 – 841.35) | |
| < 1 year old | 19(14.23; 9.08 – 22.31) | Reference group | Reference group | |
| 1 – 9 years old | 3(106.39;34.32 – 329.86) | 7.48(2.21 – 25.26) | 92.16(−28.40 – 212.72) | |
| ≥ 10 years old | 1(26.64;3.75 – 189.09) | 1.87(0.25 – 13.98) | 12.41(−40.19 – 65.00) |
Risk window defined for 28 days post-circumcision
Risk window defined for 180 days post-circumcision
Risk window defined for 365 days post-circumcision
Risk window defined for 1200 days post-circumcision
Note: Adverse events that were not encountered in this analysis, i.e. had a count of zero, were not presented to reduce the length of the table. These are: repair and plastic operation on penis.
CI: confidence interval
N.A.: not applicable